Please join us on November 30 as we introduce the new Twist Exome 2.0 target enrichment panel. Exome 2.0, designed to detect rare and inherited diseases and germline cancers, is the latest addition to our robust and ever advancing NGS target enrichment portfolio. With superior coverage of major genetic databases, inclusion of clinically relevant pathogenic variants, high uniformity, and low off-target rate, it eliminates compromise between performance and target inclusion.

In this webinar, Twist Biosciences Senior Field Application Scientist, Dr. Ananth Bommakanti will provide a full overview of Exome 2.0, revealing how it helps alleviate common sequencing pitfalls and provides researchers with best-in-class sequencing efficiency, on-target rate, duplicate rate, and mean target coverage — all while delivering clinically relevant content known today.

In this seminar, you will learn how Twist Exome 2.0:

• Maximizes coverage of clinically relevant regions 
• Leverages updated protein-coding gene coverage from key public databases 
• provides the value of multiple clinical panels all wrapped into one, easily customizable package